HopeStage
Back to all studies
CompletedNCT01111734

N-acetylcysteine for self-harm in adolescents

About this title

Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents

Read the official source — NCT01111734
Medication studyAges 13–21United StatesSuicide prevention
The study in practice

Understand this study

Who was this study for?

Listed age limits: 13 years to 21 years.

What did participation involve?

The protocol includes: Having magnetic resonance imaging (MRI) scans.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2011
Recruitment status
Completed
Enrollment listed in the registry
67
Sponsor
University of Minnesota
Sponsor type
University
Study type
Drug
Intervention type
Dietary supplement, Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 13 Years to 21 Years
Official registry ID
NCT01111734
Official title
Show the full official title

N-Acetylcysteine in the Treatment of Deliberate Self-Harm in Adolescents: An Open Label Pilot Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Did this study involve medication?

Yes. The study involved medication, including fMRI.

Who was this study for?

Listed age limits: 13 years to 21 years.

Want to explore more studies?

Explore studies